RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.

IF 9.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Alexander Chang, Halil Beqaj, Leah Sittenfeld, Marco C Miotto, Haikel Dridi, Gloria Willson, Carolyn Martinez Jorge, Jaan Altosaar Li, Steven Reiken, Yang Liu, Zonglin Dai, Carl Tchagou, Sana Elsayed, Steven O Marx, Andrew R Marks
{"title":"RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.","authors":"Alexander Chang, Halil Beqaj, Leah Sittenfeld, Marco C Miotto, Haikel Dridi, Gloria Willson, Carolyn Martinez Jorge, Jaan Altosaar Li, Steven Reiken, Yang Liu, Zonglin Dai, Carl Tchagou, Sana Elsayed, Steven O Marx, Andrew R Marks","doi":"10.1161/CIRCEP.124.013757","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia, with pathogenic variants in the <i>RYR2</i> gene responsible for 60% of clinically well-defined CPVT cases. Diagnosis of CPVT often occurs after a major cardiac event, posing a severe threat to the patient's life. A data set of patients with CPVT would improve the diagnosis and treatment of patients with CPVT.</p><p><strong>Methods: </strong>This review cataloged clinical data on patients with <i>RYR2</i>-related CPVT variants from articles published up to October 2020 from PubMed, Scopus, and Embase. Variants were mapped to the structural domains of RYR2. Differences in the age of onset based on variant location and incidence of CPVT symptoms, and differences in treatment strategies were analyzed.</p><p><strong>Results: </strong>In 221 publications analyzed, 964 patients with CPVT (351 male, 463 female) were identified with 263 <i>RYR2</i> protein-coding variants and a median age of onset of CPVT of 11 years (interquartile range, 7-14 years). A web app was developed to allow users to query the database and is available at https://markslab-cpvtdb.org. The proportion of patients requiring treatments in addition to β-blockers varied between variants. The age of onset of CPVT differed significantly between <i>RYR2</i> variants located in different exons, domains, and subdomains. Patients with variants in the core solenoid at the domain level, and the core solenoid (exEF-hand) and channel pore at the subdomain level, tended to have a lower age of onset compared with other regions.</p><p><strong>Conclusions: </strong>This study compiled a comprehensive data set of CPVT-associated <i>RYR2</i> variants and their clinical phenotypes. The age of onset in certain domains (core solenoid) and subdomains (core solenoid[exEF-hand], channel pore) tended to be lower compared with other regions. Variability in patient phenotypes, such as age of onset and treatment efficacy, along with structural information on variants, suggests that patients may benefit from personalized interventions based on their variant.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013757"},"PeriodicalIF":9.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12442783/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation. Arrhythmia and electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCEP.124.013757","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia, with pathogenic variants in the RYR2 gene responsible for 60% of clinically well-defined CPVT cases. Diagnosis of CPVT often occurs after a major cardiac event, posing a severe threat to the patient's life. A data set of patients with CPVT would improve the diagnosis and treatment of patients with CPVT.

Methods: This review cataloged clinical data on patients with RYR2-related CPVT variants from articles published up to October 2020 from PubMed, Scopus, and Embase. Variants were mapped to the structural domains of RYR2. Differences in the age of onset based on variant location and incidence of CPVT symptoms, and differences in treatment strategies were analyzed.

Results: In 221 publications analyzed, 964 patients with CPVT (351 male, 463 female) were identified with 263 RYR2 protein-coding variants and a median age of onset of CPVT of 11 years (interquartile range, 7-14 years). A web app was developed to allow users to query the database and is available at https://markslab-cpvtdb.org. The proportion of patients requiring treatments in addition to β-blockers varied between variants. The age of onset of CPVT differed significantly between RYR2 variants located in different exons, domains, and subdomains. Patients with variants in the core solenoid at the domain level, and the core solenoid (exEF-hand) and channel pore at the subdomain level, tended to have a lower age of onset compared with other regions.

Conclusions: This study compiled a comprehensive data set of CPVT-associated RYR2 variants and their clinical phenotypes. The age of onset in certain domains (core solenoid) and subdomains (core solenoid[exEF-hand], channel pore) tended to be lower compared with other regions. Variability in patient phenotypes, such as age of onset and treatment efficacy, along with structural information on variants, suggests that patients may benefit from personalized interventions based on their variant.

儿茶酚胺能多态性室性心动过速患者的RYR2变异:来自蛋白质结构和临床数据的见解。
背景:儿茶酚胺能多形性室性心动过速(CPVT)是一种罕见的遗传性心律失常,临床上明确的CPVT病例中有60%是由RYR2基因的致病变异引起的。CPVT的诊断通常发生在重大心脏事件后,对患者的生命构成严重威胁。CPVT患者数据集的建立将提高对CPVT患者的诊断和治疗水平。方法:本综述编目了截至2020年10月PubMed、Scopus和Embase上发表的有关ryr2相关CPVT变异患者的临床数据。变异被映射到RYR2的结构域。分析不同部位、不同发生率CPVT症状的发病年龄差异及治疗策略差异。结果:在分析的221篇文献中,964名CPVT患者(351名男性,463名女性)被鉴定出263个RYR2蛋白编码变异体,CPVT发病的中位年龄为11岁(四分位数范围为7-14岁)。开发了一个网络应用程序,允许用户查询数据库,可在https://markslab-cpvtdb.org上获得。除了β受体阻滞剂外,需要治疗的患者比例因变体而异。位于不同外显子、结构域和子结构域的RYR2变异的CPVT发病年龄存在显著差异。与其他区域相比,核心螺线管在区域水平变异,核心螺线管(exEF-hand)和通道孔在子区域水平变异的患者往往发病年龄较低。结论:本研究编制了cpvt相关RYR2变异及其临床表型的综合数据集。与其他区域相比,某些区域(核心螺线管)和子区域(核心螺线管[exEF-hand],通道孔)的发病年龄往往较低。患者表型的可变性,如发病年龄和治疗效果,以及变异的结构信息,表明患者可能受益于基于其变异的个性化干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.70
自引率
4.80%
发文量
187
审稿时长
4-8 weeks
期刊介绍: Circulation: Arrhythmia and Electrophysiology is a journal dedicated to the study and application of clinical cardiac electrophysiology. It covers a wide range of topics including the diagnosis and treatment of cardiac arrhythmias, as well as research in this field. The journal accepts various types of studies, including observational research, clinical trials, epidemiological studies, and advancements in translational research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信